Description
The Wolverine Pen pairs two of the most widely studied regenerative research peptides β BPC-157 and TB-500 β in a single pre-filled, dial-a-dose pen. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide studied for its interaction with angiogenic and cytoprotective signaling pathways, including VEGFR2 and nitric oxide (eNOS) activity. TB-500, the synthetic form of the active region of Thymosin Beta-4, is studied for its role in actin regulation, cell migration, and vascular remodeling. In controlled laboratory settings, the combination is examined for the complementary receptor and signaling-pathway activity of both compounds. Supplied ready to use in a pre-filled pen, it offers precise, repeatable measurement for research protocols without any mixing or reconstitution β making it a convenient blend for tissue-repair, angiogenesis, and regenerative-signaling research.
Important Note
This blend is not approved for human consumption, medical use, or diagnostic purposes. It is supplied strictly for laboratory research only. Handling should be performed by qualified professionals in an appropriate controlled research setting.
Dosage Reference Chart (Research Use Only)
| Form | Total Strength | Measurement | Notes |
|---|---|---|---|
| Pre-Filled Pen | 20mg per pen (BPC-157 10mg + TB-500 10mg) | Dial-a-dose, adjustable per click | Ready to use; refrigerate between uses |
| Experimental Dosing | Variable by study | Set on pen dial | Preclinical / literature-based models only |
Features & Properties
Fixed-ratio combination of BPC-157 (10mg) and TB-500 (10mg) in one pen
Supplied pre-filled and ready to use β no reconstitution required
Dial-a-dose pen allows precise, repeatable measurement for research protocols
BPC-157 studied for angiogenic and cytoprotective signaling (VEGFR2, eNOS pathways)
TB-500 studied for actin regulation, cell migration, and vascular remodeling
Examined for the complementary signaling-pathway activity of both peptides
Manufactured under research-grade quality standards with HPLC-verified purity β₯99%
Storage & Stability
Store refrigerated at 2β8Β°C at all times
Do not freeze the pen
Protect from direct sunlight and heat
Recap the pen and store upright between uses
Follow standard aseptic handling for each measurement
Usage Restrictions
For laboratory research use only
Not approved for human consumption, medical use, or diagnostic purposes
Handling should be performed by qualified professionals in controlled research settings
Store securely and keep out of reach of children
Do not handle during pregnancy or breastfeeding
Frequently Asked Questions
Q1. What does the pen contain? Each pen is pre-filled with a 20mg blend β 10mg BPC-157 and 10mg TB-500 β already in solution.
Q2. Do I need to mix or reconstitute it? No. The pen is ready to use straight from refrigerated storage β no bacteriostatic water or mixing required.
Q3. How is the amount measured? The pen uses a dial-a-dose mechanism, allowing precise, repeatable measurement for research protocols.
Q4. How should it be stored? Refrigerate at 2β8Β°C. Do not freeze. Protect from direct sunlight. Recap and store upright between uses.
Q5. Is it sterile? Yes, it is prepared and sealed under sterile laboratory conditions. Use aseptic technique for each measurement.
Q6. Is this product for human use? No. This blend is intended for research use only. It is not approved for medical or veterinary use.
Q7. What purity standard is used? Every batch is HPLC-verified to β₯99% purity and third-party tested.
Q8. What is the difference between the pen and a vial? The pen is pre-filled and ready to use with a dial-a-dose mechanism, while a lyophilized vial requires reconstitution with bacteriostatic water before use.
Q9. How stable is the pen during shipping? It ships cold-chain where required. Transfer to refrigerated storage (2β8Β°C) immediately upon arrival.
Q10. Who can handle this product? Only qualified laboratory researchers with appropriate training in peptide handling and proper protective equipment.





Reviews
There are no reviews yet.